CURATIO THERAPEUTICS
CREATIVITY DRIVEN INNOVATION
CREATIVITY DRIVEN INNOVATION
A potentially game-changing therapeutic for glioblastoma multiforme that has shown anecdotal evidence in humans of safety, efficacy and multi-year survival with good quality of life in the most aggressive forms of the disease commencing therapy during end stage of disease.
A novel platform for oral administration of DNA/RNA, proteins, biologics, biosimilars and other large molecules.
A first in class disease modifying osteoarthritis drug.
A novel amniotic membrane therapy for diabetic ulcers, pressure ulcers and corneal ulcers.
Our Pipeline is comprised by 4 LMPs:
Our mission and base strategy
